Tag: WHO

  • Trump formally notifies UN of US withdrawal from WHO

    Trump formally notifies UN of US withdrawal from WHO

    The United States has formally notified the United Nations of its withdrawal from the World Health Organization.

    The withdrawal notification fulfils President Donald Trump’s vow in late May to terminate U.S. participation in the WHO.

    The US president has repeatedly criticised the WHO over its response to the coronavirus pandemic and has accused it of bowing to Chinese influence.

    However, the pullout won’t take effect until next year, meaning it could be rescinded under a new administration if circumstances change.

    The withdrawal notice was sent to U.N. Secretary-General Antonio Guterres on Monday and will take effect in a year, on July 6, 2021, the US State Department and the United Nations said on Tuesday.

    Under the terms of the withdrawal, the U.S. must meet its financial obligations to the WHO before it can be finalised.

    The US, which is the agency’s largest donor and provides it with more than $400 million per year, currently owes the WHO some $200 million in current and past dues.

    In late May, less than two weeks after warning the WHO that it had 30 days to reform or lose US support, Trump announced his administration was leaving the organisation due to what he said was its inadequate response to the initial outbreak of the coronavirus in China’s Wuhan province late last year.

  • WHO team to China to consult with Chinese side on virus trace work: epidemiologist

    WHO team to China to consult with Chinese side on virus trace work: epidemiologist

    The World Health Organization (WHO) plans to send a team to China next week to prepare to
    identify the source of coronavirus, and Chinese experts believe the team should hold discussions
    with the Chinese side on how to conduct the work globally and fairly, noting that the visit does not
    mean the virus originated in China. 
    We can fight the virus better when we know everything about the virus, including how it started,
    WHO Director-General Tedros Adhanom Ghebreyesus told a virtual press conference on
    Monday. 
    "We will be sending a team next week to China to prepare for that and we hope that that will lead
    into understanding how the virus started and what we can do for the future to prepare," he said. He
    did not specify who will be in the team, nor what their specific mission will be.
    Zeng Guang, chief epidemiologist of the Chinese Center for Disease Control and Prevention, told
    the Global Times on Tuesday that although the exact arrangements for the WHO team are
    unknown, the team should communicate with Chinese experts on the preparation work to
    scientifically identify the source of the coronavirus and how the identification work should be
    conducted, and the team should also listen to Chinese experts' opinions on it. 
    It's not an easy job, and a great deal of preparation must be made, such as discussing the technical
    methods to research and identify the source, Zeng said. 
    "Identifying the source of the coronavirus must be based on negotiations and involve multiple
    countries," Zeng said.
    The WHO should have a top-level design on identifying the source of coronavirus. First, all
    evidence on the source of must be collected globally, and then be ordered according to when they
    happened, and then teams must be sent to all the involved countries for scientific identification
    and research, Zeng said. 
    "It does not matter which country the scientific identification work starts with, as long as it
    involves all related countries and is fairly conducted," Zeng said. 
    A resolution on identifying the zoonotic source of the coronavirus and evaluating the WHO's
    COVID-19 response was agreed by all the member states, including China, the US and Australia,
    at the 73rd World Health Assembly (WHA) meeting in May, rejecting political bias led by some
    Western politicians.
    Some US and Australian politicians including US Secretary of State Mike Pompeo have, without
    any proof, repeatedly blamed China for causing the coronavirus pandemic and accused a Wuhan
    lab of leaking the virus. China has reiterated that the origin and transmission pattern of the
    coronavirus are a scientific question and should be left to scientists and medical experts to study,
    and experts from the WHO have repeatedly said that there is no evidence to show that the
    coronavirus was made in a lab. 
    Six months after the coronavirus outbreak, the world has seen 10 million coronavirus cases and
    500,000 deaths.
    Source: Global Times

  • Hydroxychloroquine COVID-19 prevention trials incomplete: WHO

    Hydroxychloroquine COVID-19 prevention trials incomplete: WHO

    Hydroxychloroquine can be ruled out as a treatment for hospitalised COVID-19 patients — but the World Health Organization said Thursday it was aware of ongoing trials into its value as a preventative measure.

    A decades-old malaria and rheumatoid arthritis drug, hydroxychloroquine has been at the centre of political and scientific controversy.

    On Wednesday, the WHO decided to halt its trials of the drug for novel coronavirus patients in the hospital, after evidence from its own work and others that it had no effect on reducing the mortality rate.

    But the UN health agency said Thursday that evidence from non-WHO trials into whether it might or might not be useful in preventing against the virus had not yet concluded.

    “As far as the use of hydroxychloroquine for prophylaxis or prevention of COVID-19 — either before or after exposure — the last word is not yet out,” WHO chief scientist Soumya Swaminathan told a virtual press conference.

    “There are some good and big trials going on, and we hope those will be completed so that we have the kind of evidence that we need to make sure that patients receive the drugs which help — and do not receive drugs which do not help.”

    Hydroxychloroquine has been touted as a possible treatment for the new coronavirus by high profile figures, including US President Donald Trump.

    The drug has been included in several randomised clinical trials — considered the gold standard for clinical investigation — but the WHO said the evidence had led it to call time on its own trials.

    “What is clear now is hydroxychloroquine does not have — we know for sure now — does not have an impact on the disease in mortality in hospitalised COVID-19 patients,” said Swaminathan, an Indian paediatrician.

    “Where there is still a gap is: does it have any role at all in prevention, or in minimising the severity in early infection? We don’t know that, as yet,” she said.

    Hydroxychloroquine is being tested on healthcare workers and others with heightened exposure to the virus in large, randomised trials.

  • COVID-19: WHO resumes clinical trial of Hydroxychloroquine

    COVID-19: WHO resumes clinical trial of Hydroxychloroquine

    The World Health Organization has resumed its trial of hydroxychloroquine, after a temporary suspension of the trial for purported safety concerns.

    W.H.O’s director general, Tedros Ghebreyesus said at a news conference in Geneva, that the Data Safety Monitoring Board decided there was no reason to discontinue the international trial after reviewing available data on the drug.

    Last week, WHO announced suspension of the trial of the drug, popular for the treatment of malaria after a medical journal published that hospitalized Covid-19 patients treated with hydroxychloroquine had a higher risk of death than those who didn’t take it.

    Numerous clinical trials are looking to see if it is effective in fighting Covid-19, but it is not yet a proven treatment.

  • WHO suspends trial of hydroxychloroquine as Covid-19 treatment over safety concerns

    WHO suspends trial of hydroxychloroquine as Covid-19 treatment over safety concerns

    The World Health Organisation said Monday that it had “temporarily” suspended clinical trials of hydroxychloroquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.

    The decision came after the publication last week of a study in the Lancet indicating that the using the drug on COVID-19 patients could increase their likelihood of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference, adding that the WHO-backed trials had been “suspended while the safety is reviewed.”

    Details soon…

  • COVID-19: Nigeria lauds Africa CDC, WHO for providing trainings

    COVID-19: Nigeria lauds Africa CDC, WHO for providing trainings

    The Nigeria Centre for Disease Control (NCDC) says the proactive steps by Africa CDC to National Public Health Institutes in strengthening the response capacity of Coronavirus (COVID-19) pandemic is commendable.

    Dr Chikwe Ihekweazu, the Director General (NCDC) made the commendation while speaking to the News Agency of Nigeria (NAN) on Thursday in Abuja.

    Ihekweazut said that when the first COVID-19 case was confirmed in China, AfricaCDC and World Health Organisation Africa Region (WHOAFRO) were proactive in preparing countries in Africa.

    He said that the agencies provided training to laboratory, risk communication, Infection Prevention and Control (IPC), and case management personnel in Nigeria.

    The director-general stated that the personnel who were trained were tasked with the responsibility of training more colleagues in Nigeria.

    He noted that this enabled better preparedness when the first case of COVID-19 was detected in the country, as laboratory scientists in the five Molecular Laboratories had been trained and risk communications had begun.

    Ihekweazu said that the AfricaCDC has supported the deployment of additional human resource across states in the country.

    “We’ve also received critical laboratory and medical supplies from AU through the AfricaCDC to strengthen the response capacity in African countries.

    “We’re grateful for the coordination and leadership provided by AfricaCDC including regular learning sessions among National Public Health Institutes in Africa, as we respond to COVID19 in the country,” he said.

    NAN recalls that on Feb. 27, the Minister of Health, Dr Osagie Ehanire, confirmed a case of the coronavirus disease (COVID-19) in Lagos.

    The patient, a male Italian, travelled from Milan to Lagos on Feb. 25.

    He was confirmed positive to the virus infection at the Virology Laboratory, Lagos University Teaching Hospital.

    Africa CDC deployed one epidemiologist to Nigeria to support assessment and response to the outbreak, and has shipped 1,000 COVID-19 laboratory test kits to the country.

    This is in addition to test kits provided to representatives of Nigeria who attended the training on COVID-19 laboratory diagnostics organised by Africa CDC for 16 African countries in Dakar, Senegal, three weeks after the case was announced, and other test kits supplied by the WHO.

    NAN also reports that Africa CDC strengthens the capacity and capability of Africa’s public health institutions.

    It also partners to detect and respond quickly and effectively to disease threats and outbreaks, based on data-driven interventions and programmes. 

  • COVID-19 cases increase by 47% in Africa – WHO

    COVID-19 cases increase by 47% in Africa – WHO

    The World Health Organisation (WHO) says there has been a 47 per cent increase in the number of confirmed cases of COVID-19 in the African Region in the past week.

    The WHO Regional Office for Africa in Brazzaville, Congo, gave the update on its official twitter account @WHOAFRO on Thursday.

    READ ALSO: ECOWAS Commission denies ordering COVID Organic medication

    The agency said the coronavirus disease 2019 (COVID-19) outbreak continued to evolve in the WHO African Region since the first case was reported on February 25, 2020 in Algeria.

    Since then, the disease has spread to over 30 countries in less than a month, now affecting all member states except for Lesotho.

    Meanwhile, in COVID-19 WHO African Region External Situation Report 9, issued on May 6, the agency said the latest country to report a confirmed case was Comoros, which did on 30 April, 2020.

    “Since our last situation report, an additional 10, 577 confirmed COVID-19 cases (47 per cent increase) and 294 additional deaths ( 33 per cent increase) were reported across the WHO African Region.

    “During this period, a sharp rise in the number of confirmed COVID-19 cases was observed in five countries: Sao Tome and Principe (from 11 to 171 cases, representing 1,455 per cent increase), and Guinea Bissau (from 77 to 292 cases, 279 per cent)

    “Chad (from 52 to 170 cases, representing 227 per cent increase) Nigeria (from 1,532 to 2,950 cases, 93 per cent) and Central African Republic (from 50 to 94 cases, 88 per cent).

    “Meanwhile, five countries, including Eritrea, Mauritius, Namibia and Seychelles have reported zero new confirmed COVID-19 cases.

    “Of note, Namibia, Seychelles and Eritrea have reported zero new confirmed COVID-19 cases in the past 30, 28 and 16 days, respectively.

    “As of 5 May, 2020, a cumulative total of 32, 953 confirmed COVID-19 cases with 1,193 deaths (case fatality ratio 3.6 per cent) have been reported across the 46 affected countries in the region,” it said.

    Currently, it stated that the majority of the countries in the region were experiencing local transmission of COVID-19 and the number of countries with widespread community transmission also increasing.

    “The region has also observed increased incidences of importation of cases from affected countries within the region.

    “Overall, in the African continent, a total of 49,121 cases and 1, 956 deaths (case fatality ratio 4.0 per cent) have been reported as of 5 May, 2020.

    “This includes 32,953 cases and 1,193 deaths in the WHO African Region and 16,168 cases and 763 deaths in the WHO Eastern Mediterranean Region,’’ it added.

  • 80,000 new cases of COVID-19 reported daily – WHO

    80,000 new cases of COVID-19 reported daily – WHO

    Dr Tedros Ghebreyesus, the Director-General of World Health Organisation (WHO), says an average of 80,000 new cases of COVID-19 are being reported daily since the beginning of April

    Ghebreyesus disclosed the figure in his speech at a news conference in Geneva.

    The speech was posted on WHO website.

    According to him, more than 3.5 million cases of COVID-19 and almost 250,000 deaths have now been reported to WHO.

    “But these are not just numbers – every single case is a mother, a father, a son, a daughter, a brother, sister or friend.

    “Although the number of cases reported from Western Europe is declining, more cases are being reported every day from Eastern Europe, Africa, South-East Asia, the Eastern Mediterranean and the Americas.

    “However, even within regions and within countries, we see divergent trends; every country and every region needs a tailored approach.

    “But the impact of the pandemic goes far beyond the numbers of cases and deaths,” he said.

    The director-general said the pandemic had caused severe disruption to essential health services – including to community-based health care around the world.

    “Although professional health workers like doctors and nurses play crucial roles, in many countries trained members of the community play a vital role in delivering essential health services,” he said.

    Such services, he said, included vaccination, pre-natal screening as well as detection, prevention and management of many diseases.

    He said WHO, UNICEF and the International Federation of the Red Cross had published guidance for countries on how to maintain community-based health care in the context of COVID-19.

    “It includes practical recommendations for countries on sustaining essential services at the community level, leveraging community health workers for the response to COVID-19 while keeping them safe, and advice for how to adapt services for specific diseases and age groups.

    “For example, it suggests using telemedicine wherever possible, and leaving insecticide-treated nets for malaria at the door of households, instead of asking people to collect them from a central location.

    “It’s also vital that countries pay careful attention to the most vulnerable members of their societies.

    “Crises can exacerbate existing inequalities, which is demonstrated in higher rates of hospitalisation and death among certain populations in many countries.

    “We must address this now and in the long-term by prioritising diagnosis and care for those who are most at risk,’’ Ghebreyesus said.

    The director-general, who said this was not only the right thing to do, but “it’s the smart thing to do.

    “We cannot end the pandemic until we address the inequalities that are fueling it.

    “Today’s guidance complements the United Nations framework for the socio-economic response to COVID-19 published last week.

    “The framework lays out a “recovery roadmap” for countries to protect lives and livelihoods, and get businesses and economies up and running again as soon as possible.

    “Importantly, the framework takes a “health first” approach, recognising that strong and resilient health systems must be the foundation of recovery in all countries,” he said.

    He said WHO recommended six criteria for countries to consider as they move to ease lockdown restrictions.

    Ghebreyesus said: ” First, that surveillance is strong, cases are declining and transmission is controlled; second, that health system capacities are in place to detect, isolate, test and treat every case and trace every contact.

    “Third, that outbreak risks are minimised in special settings like health facilities and nursing homes;fourth, that preventive measures are in place in workplaces, schools and other places where it’s essential for people to go.

    “Fifth, that importation risks can be managed and sixth, that communities are fully educated, engaged and empowered to adjust to the “new norm.”

    The director-general said the risk of returning to lockdown remained very real if countries do not manage the transition extremely carefully and in a phased approach.

  • COVID-19: No evidence that people who recovered can’t be re-infected – WHO

    COVID-19: No evidence that people who recovered can’t be re-infected – WHO

    The World Health Organisation (WHO) says there is no evidence that people who recovered from COVID-19 cannot be re-infected.

    In a “Scientific Brief” released from its headquarters in Geneva on Saturday and posted on its website, WHO warned against propagating the idea of COVID-19 ‘immunity passport’.

    “Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an ‘immunity passport’.

    “They have suggested that it could serve as an ‘immunity passport’ or  ‘risk-free certificate’ that would enable individuals to travel or  return to work, assuming  they are protected against re-infection.

    “There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.

    “The development of immunity to a pathogen through natural infection is a multi-step process that typically takes place over one to two weeks,’’ WHO said.

    It said that it would continue to review the evidence on antibody responses to SARS-CoV-2 infection.

    “Most of these studies show that people who have recovered from infection have antibodies to the virus.

    “However, some of these people have very low levels of neutralising antibodies in their blood, suggesting that cellular immunity may also be critical for recovery.’’

    As at April 24, 2020, no study has evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infection by this virus in humans.”

    WHO, however, said that it supported the methodology adopted by countries to test SARS-COV-2.

    “Many countries are now testing for SARS-CoV-2 antibodies at the population level or in specific groups, such as health workers, close contacts of known cases, or within households.

    “WHO supports these studies, as they are critical for understanding the extent of,  and risk factors associated with, the  infection.

    “These studies will provide data on the percentage of people with detectable COVID-19 antibodies, but most are not designed to determine whether those people are immune to secondary infections,’’ it said.

  • COVID-19: No evidence that people who recovered can’t be re-infected – WHO

    COVID-19: No evidence that people who recovered can’t be re-infected – WHO

    The World Health Organisation (WHO) says there is no evidence that people who recovered from COVID-19 cannot be re-infected.

    In a “Scientific Brief” released from its headquarters in Geneva on Saturday and posted on its website, WHO warned against propagating the idea of COVID-19 ‘immunity passport’.

    “Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an ‘immunity passport’.

    “They have suggested that it could serve as an ‘immunity passport’ or  ‘risk-free certificate’ that would enable individuals to travel or  return to work, assuming  they are protected against re-infection.

    “There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.

    “The development of immunity to a pathogen through natural infection is a multi-step process that typically takes place over one to two weeks,’’ WHO said.

    It said that it would continue to review the evidence on antibody responses to SARS-CoV-2 infection.

    “Most of these studies show that people who have recovered from infection have antibodies to the virus.

    “However, some of these people have very low levels of neutralising antibodies in their blood, suggesting that cellular immunity may also be critical for recovery.’’

    As at April 24, 2020, no study has evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infection by this virus in humans.”

    WHO, however, said that it supported the methodology adopted by countries to test SARS-COV-2.

    “Many countries are now testing for SARS-CoV-2 antibodies at the population level or in specific groups, such as health workers, close contacts of known cases, or within households.

    “WHO supports these studies, as they are critical for understanding the extent of,  and risk factors associated with, the  infection.

    “These studies will provide data on the percentage of people with detectable COVID-19 antibodies, but most are not designed to determine whether those people are immune to secondary infections,’’ it said.